| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 487,946 | 10,691,000 | 10.61% | SH | |
| 2 | ABBVIE INC | 116,581 | 6,343,000 | 6.29% | ||
| 3 | NXSTAGE MED INC COM | 366,554 | 5,781,000 | 5.74% | SH | |
| 4 | ZS PHARMA INC | 66,194 | 4,346,000 | 4.31% | ||
| 5 | ACHILLION PHARMACEUTICALS INC COM | 480,300 | 3,319,000 | 3.29% | SH | |
| 6 | BIOCRYST PHARMACEUTICALS | 258,642 | 2,949,000 | 2.93% | SH | |
| 7 | AERIE PHARMACEUTICALS INC | 165,669 | 2,939,000 | 2.92% | SH | |
| 8 | BIOTELEMETRY INC COM | 235,645 | 2,884,000 | 2.86% | SH | |
| 9 | INSULET CORPORATION | 106,018 | 2,747,000 | 2.73% | SH | |
| 10 | RIGEL PHARMACEUTICAL INC | 1,109,740 | 2,741,000 | 2.72% | SH | |
| 11 | PROTALIX BIOTHERAPEUTICS INC | 4,000,000 | 2,698,000 | 2.68% | PRN | |
| 12 | DISCOVERY LABORATORIES INC N | 7,508,544 | 2,253,000 | 2.24% | SH | |
| 13 | INSULET CORP 2 06/15/2019 | 2,407,000 | 2,229,000 | 2.21% | PRN | |
| 14 | APPLIED GENETIC TECHNOL CORP | 157,192 | 2,066,000 | 2.05% | ||
| 15 | Otonomy Inc | 111,466 | 1,985,000 | 1.97% | ||
| 16 | MASIMO CORP COM | 46,010 | 1,774,000 | 1.76% | SH | |
| 17 | DERMA SCIENCES INC COM PAR .01 | 356,918 | 1,681,000 | 1.67% | SH | |
| 18 | XENOPORT INC | 470,612 | 1,633,000 | 1.62% | SH | |
| 19 | SYNERGY PHARMACEUTICALS DEL COM NEW | 296,563 | 1,572,000 | 1.56% | ||
| 20 | ESSA Pharma | 228,500 | 1,424,000 | 1.41% | ||
| 21 | PROTALIX BIOTHERAPEUTICS INC | 1,193,189 | 1,408,000 | 1.40% | SH | |
| 22 | CYTRX CORP | 583,013 | 1,382,000 | 1.37% | SH | |
| 23 | CARA THERAPEUTICS INC | 93,574 | 1,337,000 | 1.33% | ||
| 24 | NEOS THERAPEUTICS INC COM | 63,400 | 1,332,000 | 1.32% | ||
| 25 | Stereotaxis Inc | 1,372,862 | 1,274,000 | 1.26% | SH | |
| 26 | CELYAD SA | 30,000 | 1,256,000 | 1.25% | ||
| 27 | AVALANCHE BIOTECHNOLOGIES IN | 140,600 | 1,159,000 | 1.15% | ||
| 28 | SCYNEXIS INC | 156,904 | 1,142,000 | 1.13% | SH | |
| 29 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,062,000 | 1.05% | SH | |
| 30 | Dicerna Pharmaceuticals | 123,500 | 1,014,000 | 1.01% | ||
| 31 | NUVASIVE INC | 760,000 | 959,000 | 0.95% | PRN | |
| 32 | Ascendis Pharma | 53,241 | 942,000 | 0.93% | ||
| 33 | SPECTRANETICS CORP | 79,812 | 941,000 | 0.93% | SH | |
| 34 | ZOGENIX INC | 68,900 | 930,000 | 0.92% | ||
| 35 | JOHNSON & JOHNSON | 9,400 | 877,000 | 0.87% | SH | |
| 36 | VITAE PHARMACEUTICALS INC | 70,885 | 780,000 | 0.77% | ||
| 37 | Intec Pharma Ltd | 135,000 | 756,000 | 0.75% | ||
| 38 | ABEONA THERAPEUTICS INC | 181,818 | 736,000 | 0.73% | ||
| 39 | ARENA PHARMACEUTICALS INC | 381,600 | 729,000 | 0.72% | ||
| 40 | UNIQURE NV | 35,000 | 716,000 | 0.71% | SH | |
| 41 | CYNAPSUS THERAPEUTICS INC | 44,824 | 707,000 | 0.70% | ||
| 42 | AKARI THERAPEUTICS PLC | 26,390 | 633,000 | 0.63% | ||
| 43 | SYNERON MEDICAL LTD ORD SHS | 85,947 | 615,000 | 0.61% | SH | |
| 44 | ALDER BIOPHARMACEUTICALS INC | 18,000 | 590,000 | 0.59% | ||
| 45 | REGULUS THERAPEUTICS INC | 90,000 | 589,000 | 0.58% | ||
| 46 | CAREDX INC | 135,927 | 567,000 | 0.56% | SH | |
| 47 | CELGENE CORP | 5,200 | 562,000 | 0.56% | ||
| 48 | GILEAD SCIENCES INC | 5,700 | 560,000 | 0.56% | ||
| 49 | Exactech Inc | 31,636 | 551,000 | 0.55% | SH | |
| 50 | IRONWOOD PHARMA | 600,000 | 537,000 | 0.53% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000019, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
